1,478 results on '"Chapple, C."'
Search Results
102. Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study
103. Investigation of neurokinin-2 and -3 receptors in the human and pig bladder
104. The acute effect of magnetic stimulation of the pelvic floor on involuntary detrusor activity during natural filling and overactive bladder symptoms
105. THE ROLE OF ATP AND ADENOSINE IN THE INHIBITION BY UROTHELIUM ON UNDERLYING PORCINE DETRUSOR MUSCLE
106. THE ROLE OF NK-2 AND NK-3 RECEPTORS IN HUMAN AND PIG DETRUSOR MUSCLE
107. FLEXIBLE CYSTOURETHROSCOPY IS THE BEST WAY FOR MONITORING PATIENTS WITH URETHRAL STRICTURE DISEASE
108. Tissue-engineered oral mucosa for substitution urethroplasty
109. Streptococci and Actinomyces induce antibodies which cross react with epithelial antigens in periodontitis
110. Nerve fibre proliferation in interstitial cystitis
111. Urological Diagnosis: History and Investigations
112. Urinary Incontinence in Adults
113. The role of α1D-adrenoceptors in prostatic contraction examined using protection studies
114. Clam cystoplasty for detrusor instability - how safe and effective is it?
115. The role of flexible cystourethroscopy in the follow up of post-urethroplasty patients
116. The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro
117. The effects of low level laser irradiation on osteoblastic cells
118. The pressure-flow plot in the evaluation of female incontinence
119. Lack of neuropeptide Y receptor detection in human bladder and prostate
120. Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial
121. A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients
122. Transurethral implantation of silicone polymer for stress incontinence: evaluation of a porcine model and mechanism of action in vivo
123. Randomized controlled trials for benign prostatic obstruction: problems and pitfalls
124. The pharmacological treatment of urinary incontinence
125. In vitro investigation of the bladder-vascular selectivity of levcromakalim and YM934 in human tissues
126. β-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review
127. A training model for transurethral injection therapy for stress incontinence
128. A comparison of ambulatory and conventional urodynamic studies in men with borderline outlet obstruction
129. Factors involved in the success of antimuscarinic treatment
130. A pilot study for a randomized controlled trial comparing the efficacy, safety and cost-effectiveness of surgical treatments of the prostate
131. The responsiveness of the ICSmale questionnaire to outcome: evidence from the ICS-'BPH' study
132. Benefit-risk evaluation of approved pharmacotherapies for the treatment of overactive bladder: A sensitivity analysis of benefits versus safety for individual OAB symptoms using multi-criteria decision analysis modelling
133. Does the presence of leak on the peri-catheter urethrogram affect the short term outcomes of urethroplasty?
134. Multi-criteria decision analysis modelling to help physicians optimise treatment in patients diagnosed with overactive bladder
135. The α1L-adrenoceptor subtype in the lower urinary tract: a comparison of human urethra and prostate
136. The value of prostate specific antigen (PSA) density and free: total PSA ratio in selecting patients with a normal digital rectal examination and intermediate total PSA levels for further investigation
137. Ambulatory and static cystometric voiding variables in women; a randomized prospective study
138. Prospective 3-year follow-up of men with BOO secondary to BPH treated by transurethral needle ablation of the prostate (TUNA)
139. Treatment of detrusor instability with neuromodulation: outcomes related to both conventional and ambulatory urodynamics
140. Stress incontinence and two types of leak point pressure; clinical relevance and relationship with urethral profilometry?
141. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction
142. Clinical uroselectivity: evidence from patients treated with slow release alfuzosin for symptomatic benign prostatic obstruction
143. Pharmacotherapy for benign prostatic hyperplasia—the potential forα1-adrenoceptor subtype-specific blockade
144. Evaluation of histological structure and its effect on the distribution of α1-adrenoceptors in human benign prostatic hyperplasia
145. A modified in vitro technique to evaluate human detrusor muscle
146. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction
147. Relaxant effects of potassium-channel openers on normal and hyper-reflexic detrusor muscle
148. Do PSA density and free:total PSA enhance the detection of prostate cancer in men with a normal DRE and a total PSA level of 4·0-10 ng/mL?
149. How do various PSA assay kits compare?
150. The knee-shoulder position and the surgical restoration of female urethral sphincter competence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.